Christopher Whitfield
Advisory Partner at Syridex Bio
About
Biopharma executive with 30+ years of leadership experience, most recently at Gilead Sciences as Regional General Manager of Africa focused on global health equity, and formerly CEO of Eli Lilly South Africa. Holds an MBA from Duke's Fuqua School of Business.
Colleagues at Syridex Bio
Anindya Roychowdhury
Investor at Syridex Bio
Ben Duster
Investor at Syridex Bio
Charles Corpening
Investor at Syridex Bio
Joshua Adeoye
Principal at Syridex Bio
Kamil Ali-Jackson
Investor at Syridex Bio
Owen May
Investor at Syridex Bio
Squire Servance
Founder and Managing Partner at Syridex Bio
Stephanie D. Taylor
Investor at Syridex Bio